Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision banner 'Revision: v3.4.2'; removed the previous revision banner 'Revision: v3.4.1' and the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA government funding lapse notice with operating status links was added, and the site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded UI label Show glossary and metadata entries Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe publications note at the bottom was updated to indicate PubMed-listed publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.